- Home
- LNTH vs ENLT Comparison
LNTH vs ENLT Comparison
Compare LNTH & ENLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- ENLT
- Stock Information
- Founded
- LNTH 1956
- ENLT 2008
- Country
- LNTH United States
- ENLT Israel
- Employees
- LNTH N/A
- ENLT N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ENLT
- Sector
- LNTH Health Care
- ENLT
- Exchange
- LNTH Nasdaq
- ENLT Nasdaq
- Market Cap
- LNTH 3.6B
- ENLT 2.9B
- IPO Year
- LNTH 2015
- ENLT 2023
- Fundamental
- Price
- LNTH $58.21
- ENLT $27.07
- Analyst Decision
- LNTH Strong Buy
- ENLT Hold
- Analyst Count
- LNTH 6
- ENLT 3
- Target Price
- LNTH $105.50
- ENLT $24.00
- AVG Volume (30 Days)
- LNTH 2.5M
- ENLT 32.9K
- Earning Date
- LNTH 08-06-2025
- ENLT 08-06-2025
- Dividend Yield
- LNTH N/A
- ENLT N/A
- EPS Growth
- LNTH N/A
- ENLT N/A
- EPS
- LNTH 3.77
- ENLT 0.17
- Revenue
- LNTH $1,520,653,000.00
- ENLT $428,715,000.00
- Revenue This Year
- LNTH $4.57
- ENLT $355.90
- Revenue Next Year
- LNTH $9.41
- ENLT $42.83
- P/E Ratio
- LNTH $15.42
- ENLT $27.38
- Revenue Growth
- LNTH 5.75
- ENLT 39.54
- 52 Week Low
- LNTH $47.25
- ENLT $14.01
- 52 Week High
- LNTH $118.21
- ENLT $27.60
- Technical
- Relative Strength Index (RSI)
- LNTH 40.12
- ENLT 62.22
- Support Level
- LNTH $55.00
- ENLT $26.03
- Resistance Level
- LNTH $56.16
- ENLT $26.97
- Average True Range (ATR)
- LNTH 2.52
- ENLT 0.56
- MACD
- LNTH 0.57
- ENLT 0.18
- Stochastic Oscillator
- LNTH 41.41
- ENLT 88.60
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.